European Commission Extends Export Test for Corona Vaccines
Corona vaccine manufacturers in the European Union must continue to seek approval until at least the end of June if they wish to export vaccines.
The European Commission has extended the export test, with which EU countries and the Commission can stop the export of vaccines.
The measure took effect at the beginning of last month and was due to expire at the end of March. The export test was supposed to strengthen the committee’s grip on the supply of vaccines. Brussels saw with sorrow that the supply of vaccines for the EU was disappointing, while countries such as the United Kingdom and the United States were in full swing.
The six vaccine makers who have contracted with the European Commission must notify the EU country from which they operate in advance if they wish to ship vaccines to a country outside the EU.
That country can ban exports if the company does not live up to its agreements with the EU, as happened to AstraZeneca. Two weeks ago, Italy blocked a shipment of vaccines from the British-Swedish manufacturer that was destined for Australia. The committee, which has the final say in such a decision, agreed.
Restrictions on vaccine exports have been much discussed for months, as critics say they could spark a “vaccine war.” They force other countries to take countermeasures. Nobody benefits from such a chain reaction because vaccine supplies are often made in very different places. They sometimes travel all over the world before they can be stung.